A sampling of articles from Pharmaceutical Technology's print edition and Sourcing & Management newsletter.
Subscribe to
Pharmaceutical Technology's Sourcing and Management and
ePT, and/or the monthly magazine
Pharmaceutical Technology.
February 2012
January 2012
December 2011
November 2011
February 2012
Strategies for Value Creation in the Biopharmaceutical Industry
Patricia Van Arnum, Senior Editor, Pharmaceutical Technology
Improving R&D productivity, life-cycle management, and operational efficiency are key approaches for enhancing growth prospects.
A Mixed Year for US Biotech Financing
Patricia Van Arnum, Senior Editor, Pharmaceutical Technology
Venture-capital financing was up last year in the US biotechnology industry, but public-equity financing, exclusive of debt, declined.
Contract Services in 2012
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
Pharmaceutical Companies Target Neglected Tropical Diseases
Patricia Van Arnum, Senior Editor, Pharmaceutical Technology
Pharmaceutical companies pledge donations of 14 billion treatments for the next decade to combat nine neglected tropical diseases.
CSR and Sustainability in the News
January 2012
API Market Outlook
Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management
The market for contract API manufacturing and fine chemicals is forecast to be fairly strong, and growth for generic APIs is expected to outpace growth for innovator APIs.
Biopharmaceutical Executive Outlook
Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management
Biopharmaceutical executives share their perspective on the key issues influencing growth and innovation.
Troublesome Signs for Bio/Pharmaceutical R&D
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Pharma Companies Partner in Vaccine Development and Manufacturing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management
The pharmaceutical majors advance vaccines for the developing world.
CSR and Sustainability in the News
December 2011
Patent Reform and the Pharmaceutical Industry: From First-To-File To Post-Grant Review And Beyond
Courtenay C. Brinckerhoff, partner of Foley & Lardner LLP, vice-chair of the firm's chemical, biotechnology and pharmaceutical practice, and editor of PharmaPatentsBlog.com.
The author discusses the major changes in US patent laws as a result of the recently signed patent-reform law and the implications for pharmaceutical companies.
Technical Perspective: Antibody Drug Conjugates
Patricia Van Arnum, senior editor of Pharmaceutical Technology and editor of Sourcing and Management
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Biosimilars' Technology Needs
Eric Langer, president of BioPlan Associates
Biosimilar manufacturers need better expression systems and analytical tools to compete.
Pharmaceutical Companies Target Green Manufacturing
A roundup of pharmaceutical companies' sustainability objectives and key projects.
World Health Organization Issues Progress Report on Combating HIV/AIDS
Patricia Van Arnum, senior editor of Pharmaceutical Technology and editor of Sourcing and Management
International efforts, including improving access to medicines, have contributed to stemming the rise of HIV/AIDS in the developing world.
CSR and Sustainability in the News
Patricia Van Arnum, senior editor of Pharmaceutical Technology and editor of Sourcing and Management
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.
November 2011
Pfizer Outlines Its Supply Strategy
Patricia Van Arnum, senior editor of Pharmaceutical Technology and editor of Sourcing and Management
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.
Preparing for the Last War
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Energy Conservation in Pharmaceutical Manufacturing
L. ShamKishore is technology transfer officer, K. Manmadha Reddy is executive, technology transfer, and A. Kumar Pathy is deputy manager of technology transfer, Neuland Laboratories.
The authors discuss opportunities for energy efficiency in pharmaceutical manufacturing.
Pharma Companies Focus on Advancing Women
Pharmaceutical companies join international efforts to reduce maternal and child mortality in the developing world.
CSR and Sustainability in the News